Robert Chess, Director at NEKTAR THERAPEUTICS (NKTR), sold 8,000 shares at $18.98 ($152K) on 2021-04-14, disclosed to the SEC on 2021-04-16.
Open-market sale of $152k NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2026-02-18 | $105K | — | Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2025-01-10 | $250K | — | Filing → |